Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10
Published March 27, 2024 · Recall initiated: February 20, 2024
Summary
FDA records drug Class II recall D-0390-2024, published March 27, 2024 and initiated February 20, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 335,940 vials; Lot: Lot #: 3NC23002, Exp. Date 7/24; 3NC22013, 3NC22014, 3NC22015, 3NC22016, 3NC22017, 3NC22018, Exp. Date 2/24; 3NC22020, Exp. Date 3/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out of specification for organic impurities
What to do
Voluntary: Firm initiated · Letter
Get an email if NICARDIPINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NICARDIPINE HYDROCHLORIDE
- Manufacturer
- Eugia US LLC
- Distributor
- Nationwide within the United States
- UPC
- 0355150183012
- Lot
- Lot #: 3NC23002, Exp. Date 7/24; 3NC22013, 3NC22014, 3NC22015, 3NC22016, 3NC22017, 3NC22018, Exp. Date 2/24; 3NC22020, Exp. Date 3/24
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDCAugust 26, 2026
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for:May 7, 2025
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, AmericanMay 7, 2025
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, ForMay 29, 2024
- FDADigoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70March 27, 2024
- FDANicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics PharmaMarch 27, 2024
Questions about this recall
Was Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10 recalled?
Yes. FDA published recall D-0390-2024 on March 27, 2024. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification for organic impurities
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NICARDIPINE HYDROCHLORIDE. UPC: 0355150183012.